Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing
Source abstract
Abstract
A novel triblock poly(amido amine)-poly(ethylene glycol)-poly-l-lysine (PAMAM-PEG-PLL) nanocarrier was designed, synthesized, and evaluated for the delivery of siRNA. The design of the nanocarrier is unique and provides a solution to most of the common problems associated with the delivery and therapeutic applications of siRNA. Every component in the triblock nanocarrier plays a significant role and performs multiple functions: (1) tertiary amine groups in the PAMAM dendrimer work as a proton sponge and play a vital role in the endosomal escape and cytoplasmic delivery of siRNA; (2) PEG, a linker connecting PLL and PAMAM dendrimers renders nuclease stability and protects siRNA in human plasma; (3) PLL provides primary amines to form polyplexes with siRNA through electrostatic interaction and also acts as penetration enhancer; and (4) conjugation to PEG and PAMAM reduced toxicity of PLL and the entire triblock nanocarrier PAMAM-PEG-PLL. The data obtained show that the polyplexes resulted from the conjugation of siRNA, and the proposed nanocarriers were effectively taken up by cancer cells and induced the knock down of the target BCL2 gene. In addition, triblock nanocarrier/siRNA polyplexes showed excellent stability in human plasma.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
Funding
National Cancer Institute · National Institutes of Health
References (41)
Show source-provided references
1. Caplen N. J. · Ann. N.Y. Acad. Sci. · 2003 · 1002 · 5610.1196/annals.1281.007 ↗
2. Dave R. S. · Rev. Med. Virol. · 2003 · 13 · 37310.1002/rmv.407 ↗
3. Dorsett Y. · Nat. Rev. Drug Discovery · 2004 · 3 · 31810.1038/nrd1345 ↗
4. Mello C. C. · Nature · 2004 · 431 · 33810.1038/nature02872 ↗
5. Sontheimer E. J. · Nat. Rev. Mol. Cell. Biol. · 2005 · 6 · 12710.1038/nrm1568 ↗
6. Paroo Z. · Trends Biotechnol. · 2004 · 22 · 39010.1016/j.tibtech.2004.06.004 ↗
7. Chen A. M. · Small · 2009 · 5 · 267310.1002/smll.200900621 ↗
8. Christie R. J. · Endocrinology · 2010 · 151 · 46610.1210/en.2009-1045 ↗
9. Guo P. · Adv. Drug Delivery Rev. · 2010 · 62 · 65010.1016/j.addr.2010.03.008 ↗
10. Ladewig K. · Biomaterials · 2010 · 31 · 182110.1016/j.biomaterials.2009.10.058 ↗
11. Minko T. · Methods Mol. Biol. · 2010 · 624 · 28110.1007/978-1-60761-609-2_19 ↗
12. Ozpolat B. · J. Intern. Med. · 2010 · 267 · 4410.1111/j.1365-2796.2009.02191.x ↗
13. Patil M. L. · Bioconjugate Chem. · 2008 · 19 · 139610.1021/bc8000722 ↗
14. Patil M. L. · Biomacromolecules · 2009 · 10 · 25810.1021/bm8009973 ↗
15. Schroeder A. · J. Intern. Med. · 2010 · 267 · 910.1111/j.1365-2796.2009.02189.x ↗
16. Taratula O. · J. Controlled Release · 2009 · 140 · 28410.1016/j.jconrel.2009.06.019 ↗
17. Martin M. E. · AAPS J. · 2007 · 9 · E1810.1208/aapsj0901003 ↗
18. Read M. L. · Nucleic Acids Res. · 2005 · 33 · e8610.1093/nar/gni085 ↗
19. Benns J. M. · Bioconjugate Chem. · 2000 · 11 · 63710.1021/bc0000177 ↗
20. Midoux P. · Bioconjugate Chem. · 1999 · 10 · 40610.1021/bc9801070 ↗
21. Betigeri S. · Mol. Pharm. · 2006 · 3 · 42410.1021/mp060014x ↗
22. Chen A. M. · ACS Nano · 2010 · 4 · 367910.1021/nn901796n ↗
23. Garbuzenko O. B. · Pharm. Res. · 2009 · 26 · 38210.1007/s11095-008-9755-4 ↗
24. Saad M. · Nanomedicine · 2008 · 3 · 76110.2217/17435889.3.6.761 ↗
25. Taratula, O.; Savla, R.; Wang, Y. A.; He, H.; Minko, T.Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Supermagnetic Iron Oxide Nanoparticles/Dendrimer Complexes.Curr. Drug Delivery 2011, in press.10.2174/156720111793663642 ↗
26. Chandna P. · Mol. Pharm. · 2007 · 4 · 66810.1021/mp070053o ↗
27. Majoros I. · Macromolecules · 2003 · 36 · 552610.1021/ma021540e ↗
28. Inoue Y. · J. Controlled Release · 2008 · 126 · 5910.1016/j.jconrel.2007.10.022 ↗
29. Kano, A.; Moriyama, K.; Yamano, T.; Nakamura, I.; Shimada, N.; Maruyama, A.Grafting of Poly(ethylene glycol) to Poly-lysine Augments Its Lifetime in Blood Circulation and Accumulation in Tumors without Loss of the Ability To Associate with siRNA.J. Controlled Release 2009, in press.
30. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
31. Hwang S. J. · Curr. Opin. Mol. Ther. · 2001 · 3 · 183
32. Gary D. J. · J. Controlled Release · 2007 · 121 · 6410.1016/j.jconrel.2007.05.021 ↗
33. Putnam D. · Proc. Natl. Acad. Sci. U.S.A. · 2001 · 98 · 120010.1073/pnas.98.3.1200 ↗
34. Kim S. H. · J. Controlled Release · 2006 · 116 · 12310.1016/j.jconrel.2006.05.023 ↗
35. Merkel O. M. · J. Controlled Release · 2009 · 138 · 14810.1016/j.jconrel.2009.05.016 ↗
36. Sato A. · J. Controlled Release · 2007 · 122 · 20910.1016/j.jconrel.2007.04.018 ↗
37. Schiffelers R. M. · Nucleic Acids Res. · 2004 · 32 · e14910.1093/nar/gnh140 ↗
38. Taratula O. · J. Controlled Release · 2009 · 140 · 28410.1016/j.jconrel.2009.06.019 ↗
39. Jayant S. · Pharm. Res. · 2007 · 24 · 212010.1007/s11095-007-9406-1 ↗
40. Pakunlu R. I. · Cancer Res. · 2004 · 64 · 621410.1158/0008-5472.CAN-04-0001 ↗
41. Bolcato-Bellemin A. L. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 1605010.1073/pnas.0707831104 ↗